#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ocular lymphoma Leukocyte adhesion deficiency type I Malignant glioma Crohn's disease Biotinidase deficiency Antiphospholipid syndrome Gastric cancer Chronic hepatitis B Infective uveitis Cholangitis sclerosing Paraganglion neoplasm Thalassaemia alpha Deafness Congenital pseudarthrosis Rhabdomyosarcoma recurrent More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome Gaucher’s disease type I – Life with Disease Myelodysplastic syndrome with excess blasts – Life with Disease Skin angiosarcoma – Basic Information Breast angiosarcoma metastatic – Diagnostics Hepatoblastoma – Life with Disease Antithrombin III deficiency Congenital nephrogenic diabetes insipidus – Life with Disease Mantle cell lymphoma stage IV – Diagnostics Primary hyperoxaluria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gremubamab Methylprednisolone Acetate Bio89-100 Pacritinib Corticosteroids, Plain Ralinepag Sodium Hyaluronate Zanubrutinib Diclofenac Diethylamine Imatinib Camonsertib Cetuximab Linperlisib Timolol Maleate Inupadenant Lamotrigine Omeprazole Ertapenem Rct2100 GSKVX000000034797 More therapies…

    Learn about Your Condition

    Malignant mast cell neoplasm Cutaneous calcification Parkinson's disease Atrophic vulvovaginitis Gastrectomy Dyspnoea Tendon injury Epileptic encephalopathy Hot flush Pancreatitis acute Aphthous ulcer Endocrine disorder Diabetic foot infection Lymphangiosarcoma Metastatic neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm malignant

  • A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cldn6 Car-T
    • Cldn6 Car-T(A)
    • Cldn6 Rna-Lpx
    Germany The Netherlands Sweden

  • Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • S095035
    • Tng462
    Denmark France Germany Italy Spain

  • Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • PRT3789
    • Pembrolizumab
    France Germany Spain

  • Study on the Safety and Effectiveness of GEN1078 for Patients with Malignant Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • GEN1078
    Denmark Spain

  • Study on Methadone Hydrochloride and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Methadone Hydrochloride
    • Fluorouracil
    • Folinic Acid
    Germany

  • Study on JAB-21822 for Adults with Advanced Solid Tumors with KRAS G12C Mutation

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Jab-21822
    Spain
Previous Page
1 … 9 10 11 12 13 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!